Company research
MOLECULAR PARTNERS AG
CIK 1745114Updated Sep 26, 2026
SecurityMOLN · NASDAQ · adr
MOLN price & chart
Loading TradingView…
NASDAQ:MOLN on TradingView ↗In the news
Molecular Partners Reports H1 2026 Financial Results and Corporate Highlights: DLL3 Radiotherapy MP0712 Successfully Advancing to Higher Dose Level in Phase 1/2a Study ↗
Recent filings
Show 4 more recent filings
Financials
FY 2025 · CHFSource
Source
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Profit or LossCHF | -61,651,000Source | -54,043,000Source | -61,984,000Source | 117,853,000Source |
| Additional Financial Items | ||||
| AdjustmentsForFinanceCostsCHF | 5,047,000Source | 38,000Source | 5,155,000Source | 619,000Source |
| AdjustmentsForFinanceIncomeCHF | 1,522,000Source | 7,214,000Source | 4,279,000Source | 1,859,000Source |
| AdjustmentsForIncomeTaxExpenseCHF | 2,000Source | 2,000Source | 0Source | 0Source |
| AdjustmentsForSharebasedPaymentsCHF | 4,419,000Source | 4,105,000Source | 5,207,000Source | 5,088,000Source |
| IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesCHF | — | 0Source | 0Source | 0Source |
| InterestPaidClassifiedAsOperatingActivitiesCHF | 18,000Source | 26,000Source | 34,000Source | 646,000Source |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesCHF | 1,212,000Source | 1,208,000Source | 1,198,000Source | 1,189,000Source |
| PaymentsToAcquireOrRedeemEntitysSharesCHF | — | 0Source | 0Source | 631,000Source |
| ProceedsFromIssuingSharesCHF | 0Source | 17,342,000Source | 0Source | 0Source |
| PurchaseOfIntangibleAssetsClassifiedAsInvestingActivitiesCHF | 0Source | 18,000Source | 233,000Source | 240,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Selling, General and Administrative ExpenseCHF | 15,241,000Source | 17,583,000Source | 19,362,000Source | 22,238,000Source |
| Total RevenueCHF | — | 4,970,000Source | 7,038,000Source | 189,600,000Source |
| Additional Financial Items | ||||
| ApplicableTaxRatenumber | 0.19Source | 0Source | 0Source | 0Source |
| AverageEffectiveTaxRatenumber | 0Source | — | — | — |
| BasicEarningsLossPerShareCHF/shares | -1.65Source | -1.59Source | -1.89Source | 3.63Source |
| DepreciationRightofuseAssetsCHF | 1,201,000Source | 1,200,000Source | 1,200,000Source | 1,200,000Source |
| DilutedEarningsLossPerShareCHF/shares | -1.65Source | -1.59Source | -1.89Source | 3.54Source |
| EmployeeBenefitsExpenseCHF | 37,392,000Source | 37,696,000Source | 40,016,000Source | 39,889,000Source |
| ExpenseFromSharebasedPaymentTransactionsWithEmployeesCHF | 4,277,000Source | 4,105,000Source | 5,207,000Source | 5,088,000Source |
| ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsedCHF | — | — | 0Source | 0Source |
| FinanceCostsCHF | 5,047,000Source | 38,000Source | 5,155,000Source | 619,000Source |
| FinanceIncomeCHF | 1,522,000Source | 7,214,000Source | 4,279,000Source | 1,859,000Source |
| IncomeTaxExpenseContinuingOperationsCHF | 2,000Source | 2,000Source | 0Source | 0Source |
| InterestExpenseOnLeaseLiabilitiesCHF | 18,000Source | 24,000Source | 34,000Source | 43,000Source |
| NetForeignExchangeLossCHF | 5,013,000Source | 0Source | 5,106,000Source | 0Source |
| OtherEmployeeExpenseCHF | 2,525,000Source | 2,644,000Source | 2,954,000Source | 1,473,000Source |
| OtherFinanceCostCHF | 15,000Source | 13,000Source | 15,000Source | 14,000Source |
| OtherIncomeCHF | — | 0Source | 0Source | 44,000Source |
| PostemploymentBenefitExpenseDefinedBenefitPlansCHF | 1,599,000Source | 1,467,000Source | 2,632,000Source | 3,192,000Source |
| ProfitLossBeforeTaxCHF | -61,649,000Source | -54,041,000Source | -61,984,000Source | 117,853,000Source |
| ProfitLossFromOperatingActivitiesCHF | -58,124,000Source | -61,217,000Source | -61,108,000Source | 116,613,000Source |
| ResearchAndDevelopmentExpenseCHF | 40,194,000Source | 48,604,000Source | 48,784,000Source | 50,749,000Source |